Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results ...
Consistent OS benefit in an Asian subset with a strong HR of 0.69 for non-squamous patients, and meaningful safety advantage position Plinabulin as a late-stage candidate showing survival improvement ...
Director of Research and Responsible Gaming Mark Vander Linden and Research Manager Marie-Claire Flores-Pajot will lead a presentation related to the Asian CARES Report. Other presenters include Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results